Sign in to view content

Novel Vascular Endothelial Growth-Factor A (VEGF-A) and Angiopoietin-2 (Ang-2) Bispecific Protein, RO-634, in Comparison to Aflibercept

Mark R. Barakat, MD

Video
Published 2022

Related

DRCR.net Anti-VEGF Comparative Effectiveness Trial for Diabetic Macular Edema
Neil M. Bressler, MD
Member Podcasts
Extended Q16W Dosing Potential for Faricimab in Neovascular Age-Related Macular Degeneration (nAMD): STAIRWAY Phase 2 Trial
Philip J. Ferrone, MD, FASRS
Annual Meeting Talks
2019
Retinal Vascular Disease Symposium
Annual Meeting Talks
2020

Category: Pharmacology

See more